not related to fertilization rates.
Total ribonucleic acid was isolated from follicular aspirates and GCenriched preparations. After reverse transcriptase and polymerase chain reaction cycles using oligonucleotide primers corresponding to known cDNA sequences for IL-6, a 126-basepair band characterized the amplification product of IL-6 transcripts on gel electrophoresis. To localize IL-6 messenger ribonucleic acid, in situ hybridization analysis was performed using a [3sS]IL-6 riboprobe. The distribution of transcripts was more dense (15% us. 3% stained cells) in GC-enriched preparations, which contained more than 95% GCs, than in original follicular preparations, which contained 20-40% viable GCs; it was not significantly modified by the presence of macrophage contaminants. The expression of IL-6 protein was assessed by positive immunohistological stainings. Biological IL-6 activity was higher, and i n situ hybridization signals were more dense and more intense in 24-h GC cultures than in 72-h GC cultures, suggesting that IL-6 biosynthesis was transiently induced. Under experimental conditions of low IL-6 endogenous levels in cultures, adding recombinant human IL-6 from lo-200 IU/mL had no effect on progesterone production or aromatase activity in GC cultures free of macrophages, whereas in GC cultures including macrophage contaminants, stimulatory effects on basal and hCG-stimulated progesterone production and on basal and FSH-stimulated aromatase activities were observed.
The present study provides strong support for the view that IL-6 is produced by GCs in the preovulatory follicle at the time of ovulation. In addition, we showed that IL-6 might be an intraovarian regulatory factor concerned with steroidogenesis. (J Clin Endocrirwl Metab 79: 633-642, 1994) I N RECENT years, evidence has accumulated to suggest that the immune system is an additional local regulator of ovarian function, involving reciprocity among soluble polypeptides of immunological origin, the cytokines, and the reproductive system. Numerous studies have shown that a variety of cytokines are capable of exerting profound effects on ovarian function and are the probable mediators of immune influence on reproductive processes, implicated as regulators of gonadal steroid secretion, corpus luteum function, embryo development, and implantation (1). Interleukin-6 (IL-6) is involved in numerous immunological, proliferative, and neoplasic processes (2), including follicular angiogenesis (3). More recently, evidence has emerged which demonstrates that IL-6 can directly influence ovarian function (4). IL-6 is synthesized by a variety of cell types that play important roles in both immunity and inflammation. IL-6 production is not constitutive, but is transiently induced by various stimuli, including the inflammatory process. Ovulation, initiated by the LH surge, completes an inflammatorylike process (5), triggering massive ovarian infiltration by representatives of the white blood cell series in the preovu- for 20-24 h in the presence of 20,000 washed motile sperm. After 1 day in culture, residual cumulus was detached from oocyte using thin needles, then media were pooled for each patient and centrifuged.
The supematants (day 1 medium) were collected and frozen at -20 C until assayed, and cumulus cells collected from the pellet were cultured.
After the second day of oocyte culture in fresh B2 medium, the collected medium was centrifuged and frozen until assayed (day 2 medium). 
FIG. 3.
In situ hybridization of a W-labeled human IL-6 riboprobe. a, Original preparation containing 20-40% GC. Magnification, x300. b, Enriched GC preparations not treated to remove macrophages; these preparations included more than 95% GC and 3-4% macrophage contaminants. Magnification, x300. c, Preparations enriched in GC (>95%) and cleared of macrophages. Magnification, x300. d, Enriched GC preparations after a 72-h culture period (magnification, x300). e, Density of silver grains on reactive cells from an enriched GC preparation after a 24-h culture period. Magnification, ~600 (oil immersion). f, Density of silver grains on reactive cells from enriched GC preparations after a 72-h culture period. Magnification, x600 (oil immersion). Reactive cells contain clusters of silver grains, showing the presence of IL-6 mRNA in these cells. Cells were counterstained with hematoxylin, which stained nuclei. To determine the effects of IL-6 in cultures, human recombinant IL-6 (rhIL-6; Genzyme; SA, 4 x IO7 U/mL, as determined by the 89 cell proliferation assay) was added to culture medium.
Hormone and cytokine assays P and estradiol (Ez) were assayed by RIA, using COATRIA kits (Biomerieux Laboratories, Marcy l'Etoile, France). The assay sensitivities were 0.65 ng/mL and 12 pg/mL for P and El, respectively; intra-and interassay coefficients of variation were 6% and 14%, respectively. 
FIG. 4.
Immunocytochemical identification of macrophages and IL-6 sites of production. a, Cells colored with the monoclonal CD68 antibody from GCenriched preparations that were not treated to remove macrophages. Magnification, x300. b, Cells from preparations treated to remove macrophages; no cell was colored after immunostaining with the CD68 antibody. Magnification, X300. c, Immunostaining of macrophages observed at a magnification of ~1200 (oil immersion). d, Negative control in the absence of primary antibody, at a magnification of X900 (oil immersion). e, Immunocytochemical localization of IL-6 on cell spots from GC-enriched preparations including macrophage contaminants.
Magnification, X900 (oil immersion). f, Immunocytochemical localization of IL-6 on cell spots from GC-enriched preparations cleared of macrophages. Magnification, x900 (oil immersion). Reddish brown immunostain represents cell sites of specific immunoreactivity. Cells were counterstained with hematoxylin, which produced the blue stain of the nuclei.
Results treated with RT-PCR techniques. A 126-basepair band characterizing amplification products of IL-6 transcripts was Biological IL-6 activity ranging from 20-50 IU/mL was detected in FF sample from 22 patients. For 6 of the 22 shown on the electrophoresis gels for every sample examined patients, IL-6 concentrations were measured in parallel in FF (Fig. 1) . No band was detected for peripheral monocytes.
and serum samoles collected on the dav of oocvte retrieval.
Negative controls were performed with samples not treated with RT. Biological IL-6 Aactivity was nearly undetectable in serum samnles.
Biological IL-6 activity in GC cultures
Total RNA was extracted from follicular aspirates from After determining that medium supplemented in FCS did four patients and from GC-enriched preparations, then not contain any trace of IL-6, biological IL-6 activity was In cultures cleared of macrophages (A), basal P production and the percent increment in P production induced by hCG or (Bi&cAMP were not modified by adding rhIL-6 to the culture medium, whereas in cultures including macrophages (B), P levels was significantly increased in cultures supplemented with rhIL-6. assayed in cultures. No significant differences were detected between GC cultures cleared of macrophages and GC cultures not treated with immunobeads and still containing macrophages. At the end of a 72-h culture period, IL-6 levels significantly decreased us. levels detected in 24-h cultures. In addition, IL-6 levels were lower in cultures with testosterone than in cultures with LDL (Fig. 2) . The levels of El and P were measured in cultures with LDL and cultures with testosterone; they were, respectively, 5 x lo3 pmol/L and 4.6 X lo4 nmol/L in cultures with LDL and 2.5 X lo5 pmol/ L and 8.4 X 10' nmol/L in cultures with testosterone. The addition of hCG or FSH did not significantly modify IL-6 activity in the cultures.
Determination of cellular sites of IL-6 biosynthesis
In situ hybridization techniques were performed on cell spots from original preparations including 20-40% GC (Fig.  3a) and on cell spots from GC-enriched preparations containing more than 95% GC (Fig. 3, b and c) . Cellular localization of IL-6 transcripts clearly identified sites of IL-6 synthesis. Their relative number was 15% in GC-enriched preparations VS. 3% in original preparations, showing that the higher the number of granulosa cells, the higher the number of cellular sites of IL-6 biosynthesis. The distributions of IL-6 transcripts were similar in GC-enriched preparations with 3-4% macrophage contaminants (Fig. 3b) and preparations cleared of macrophages (Fig. 3~) . Macrophages specifically colored with CD68 antibody in preparations not treated with immunomagnetic beads (Fig. 4, a and c) , whereas no staining was detected in preparations treated with immunomagnetic beads (Fig. 4b) . Immunocytochemical staining with IL-6 antibody was positive on GC-enriched preparations still containing macrophages (Fig. 4e) and those cleared of macrophages (Fig. 4f) . No staining was detected in the absence of primary antibody (Fig. 4d) .
After a 72-h culture period, the relative number of cells labeled by in situ hybridization techniques dropped to 2-3% (Fig. 3d) VS. 15% in 24-h cultures (Fig. 3c) , and the density of grains per cell was less intense (Fig. 3f) than that in 24-h cultures (Fig. 3e) . The presence or absence of serum in culture medium as well as adding or not adding hCG for 72 h did not modify levels of IL-6 transcripts. No specific staining was detected with the sense strand (control) probe.
IL-6 and oocyte fertilization rates
Biological IL-6-like activity was explored in OCC cultures (day 1 medium) and denuded oocyte-embryo supematants (day 2 medium) from 22 patients. OCC supematants from 10 patients displayed detectable IL-6 activity, whereas that of 12 patients did not show any measurable IL-6 activity, although P levels in OCC culture medium and fertilization rates were similar (P > 0.05, by Student's t test; Table 1 ). Control sperm medium and denuded oocyte-embryo supernatants (day 2 medium) showed no IL-6 activity. Slight IL-6 activity from lo-30 IU/mL was detected in 24-h cultures of cumulus cells from 5 patients. These levels were significantly lower than those detected in GC cultures under similar experimental conditions (lo-30 zIs. 110-150 IU/mL).
IL-6 and GC steroidogenesis
The effects of IL-6 on GC steroidogenesis were tested in 72-h serum-free cultures with low endogenous IL-6 activity. The effects of IL-6 were determined in GC cultures cleared of macrophages and in GC cultures including macrophage contaminants from four series of pooled follicular aspirates. In both types of cultures, P levels rose in the presence of 10e4 mol/L (Bu)~cAMP or 10 ng/mL hCG added for 24 h, and this increase was dose dependent for hCG doses from O-10 ng/mL. Adding 100 IU/mL rhIL-6 for 24 h to GC cultures cleared of macrophages had no effect on either basal P production or P production stimulated by hCG or (Bu),cAMP. However, adding 100 IU/mL IL-6 for 24 h to GC cultures including macrophages significantly increased P production in the absence and presence of hCG or (Bu)*cAMP (P < 0.01, by Scheffe's test; Fig. 5 ). This augmentation evoked a significant dose-dependent increase in stimulated P release when various concentrations of IL-6 (10, 50, 100, and 200 IU/mL) were added to a fixed concentration of 1 ng/mL hCG (Fig. 6) .
Concurrent exposure to 100 IU/mL rhIL-6 in GC cultures cleared of macrophages had no effect on aromatase activities in either the absence or presence of 10 ng/mL FSH or 10m4 mol/L (BuhcAMP (P > 0.05, by Scheffe's test). However, adding 100 IU/mL IL-6 to GC cultures containing macrophages significantly increased aromatase activities under basal conditions and in the presence of 1 and 10 ng/mL FSH and 10m4 mol/L (Bu)KAMP (P < 0.01, by Scheffe's test; Fig. 7 ).
Discussion
Evidence of IL-6 in preovulatory follicles was previously reported (8, 9). Here, IL-6-like activity ranging from 20-50 IU/mL was detected in 22 patient FF, whereas IL-6 activity was nearly undetectable in serum samples collected from 6 patients on the day of oocyte recovery. Because IL-6 is removed from the circulation with a half-life of about 3 min (15), IL-6 could be produced locally in the preovulatory follicle, whereas it was not detected in serum. Under physiological conditions, the low IL-6 levels detected in serum are at the limit of sensitivity of the biological assay we used here. Higher levels of circulating IL-6 are usually correlated with tissue damage and pathology, as recently demonstrated for women with ovarian hyperstimulation syndrome and patients with ovarian epithelial cancer (16, 17) .
RNA extracted from follicular aspirates and GC-enriched preparations, reverse transcribed, then treated with PCR reactions containing oligonucleotides primers for IL-6, showed a characteristic 126-basepair band corresponding to amplification products of IL-6 transcripts. Cellular localization of IL-6 mRNA on cell spots by in situ hybridization allowed determination of the relative number of active sites of IL-6 synthesis. These sites were more numerous in enriched GC preparations from 24-h cultures (15% of stained cells) including more than 95% granulosa cells than on the original preparation from follicular aspirates (3% of stained cells), including 20-40% viable granulosa cells. Thus, the increase in the expression of IL-6 transcripts followed the enrichment of granulosa cells; 20-40% of viable GCs in original cell preparations us. more than 95% in enriched GC preparations. Even if unidentified contaminant cells might contaminate enriched GC preparations, it was only in the range of l-5% under our experimental conditions, and in any case they could be responsible for the labeling of 15% cells. On the other hand, levels of IL-6 transcripts were similar in preparations treated to remove macrophages or untreated,, showing that IL-6 biosynthesis by macrophages was a negligible source of IL-6. Finally, sites of IL-6 produc- tion were clearly identified on GC-enriched preparations by positive immunostaining.
Evidence of IL-6 release by GCs was previously reported (4, 18, 19) . Here, characterization of IL-6 transcripts by RT-PCR, in situ hybridization staining, and immunostaining constitutes a data set that allowed identification of GC from the preovulatory follicle at the time of ovulation as an active site of IL-6 biosynthesis. These results provide strong support for the view that IL-6 activity detected in preovulatory follicles is derived to a large extent from a somatic ovarian cell. By establishing GC as sites of IL-6 production, our present findings provide yet another example of the variety of cellular IL-6 sites in the immune system (20-23).
IL-6 release by undifferentiated rat granulosa cells was shown to be up-regulated by FSH (4, 24) or agents that increase the CAMP cellular content of rat ovarian cells (19). Here, GCs were collected 36 h after the induction of ovulation by hCG, which is known to induce high concentrations of cellular CAMP (25), and we showed that these cells were active sites of IL-6 synthesis. Similarly, increments in the relative abundance of ovarian IL-16 transcripts after exposure to hCG has been previously noted in rats (26). Biological IL-6 activity was higher and in situ hybridization signals were more dense in 24-h cultures than in 72-h cultures. Here, as shown in a variety of cells, except in tumor ovarian cell lines (18), IL-6 production is probably transiently induced. The addition of hCG, which is known to maintain elevated P levels in cultures (27), did not modify IL-6 levels in terms of biological activity or in situ hybridization signals. Conversely, we noted that IL-6 levels decreased and Ez levels rose when testosterone replaced LDL in serum-free cultures, suggesting that IL-6 production by GCs might be downregulated by elevated Es levels. The inhibitory effect of estrogens on IL-6 production has been previously demonstrated in endometrial stromal cell cultures (28). Periovulatory steroidogenesis is characterized by a shift from E2 production to P production after the luteinization of GCs following the LH surge. On an other hand, it has been previously noted that the lowest plasma concentrations of IL-6 were observed during the first half of the cycle, corresponding to high circulating estrogen levels, whereas the highest concentrations of IL-6 were observed just before menstruation, corresponding to low circulating estrogen levels, probably contributing to systemic alterations in body temperature during the menstrual cycle (29). It is, therefore, tempting to speculate that IL-6 might be transiently produced by GCs at the time of ovulation.
Cytokines, including IL-6, have been suggested to influence oocyte fecundity (9). Here, the presence or absence of detectable IL-6 activity in OCC supematants did not significantly modify oocyte fertilization rates. IL-6 activity detected in OCC supernatants might originate from cumulus cells, because IL-6 activity was detected in cumulus cell cultures, whereas culture medium from denuded oocytes was devoid of IL-6 activity. In addition, we noted that IL-6 levels in cumulus cell cultures were much lower than IL-6 levels in GC cultures. Marked differences in physicochemical properties, hormonal responsiveness, and LH/hCG receptor dis-tribution have been notified between cumulus and granulosa cells (30, 31) . The present observations might constitute one more means of differentiating the two cellular types.
Although IL-6 activity detected in FF samples was usually less than 50 IU/mL, IL-6 locally derived from activated resident follicular cells including GCs may assure, by cell to cell contact, that higher concentrations of IL-6 are delivered to target cells. A variety of IL-6-responsive cells, including endothelial cells, is present in the preovulatory follicles at ovulation. In primates, the dominant follicle is richly vascularized. After ovulation and disintegration of the basal lamina, thecal vessels invade the granulosa layer, giving rise to the luteal vascular network. It seems likely that the centrally located GC are one of the factors controlling the development of luteal blood cell vessels (32); by stimulating endothelial motility (33), IL-6 produced by GC might have an active role in angiogenesis.
The periovulatory period is marked by a rise in P biosynthesis. This steroid is secreted in large amounts by GC and plays a decisive role in embryo implantation, supporting ovarian function in the early luteal phase. With exogenous P, it has been considered a rational approach to improve rates of pregnancy in patients undergoing IVF (34). Numerous cytokines have been demonstrated to up or down-regulate P release by human GCs, whereas some cytokines, including IL-1 (35, 36), tumor necrosis factor-a (37-39), and IL-6 on porcine GC (40), have no effect on steroidogenic activities of GC. Our experimental conditions achieved conditions of low endogenous IL-6 production in GC cultures, which let us test the effects of adding increasing rhIL-6 doses. In GC cultures cleared of macrophages, IL-6 had no effect on basal and stimulated steroidogenic activities of GCs. The lack of IL-6-mediated effects might occur either with or without the loss of IL-6 receptors. Future studies will be necessary to investigate the presence of IL-6 receptors on GC. Conversely, we showed that adding rhIL-6 to GC cultures containing macrophage contaminants modulated steroidogenic activities of GCs, including P production. As IL-6 did not mediate any direct effect on GCs, the activating effects of IL-6 might be induced by the release of macrophage factor(s). Mouse luteal cells have been demonstrated to produce more P when they were recombined in cultures with autologous macrophages from corpora lutea (41), whereas macrophages enhanced P production by human cultured GCs (42). During the process of aspiration, FF might be mixed with blood, and monocytes could contaminate the follicular cell population. However, previous studies showed that only a small contamination of GCs with blood monocytes existed, and mostly monocytes were present in follicular cell cultures originated from follicular tissue (7). These findings give a novel model for cytokine-mediated relations in the human preovulatory follicle by showing that macrophages, via IL-6, might be involved in GC steroidogenesis. 
